SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending due to a historic multi-day rally and surging institutional interest, fueled by strategic partnerships with AI heavyweights and a broader sector rotation into undervalued chip leaders. Community sentiment is overwhelmingly bullish, with many investors pointing to the company's long-term potential as a critical component of domestic AI infrastructure, while some traders closely monitor technical resistance levels and potential volatility surrounding upcoming earnings.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to its significantly expanded partnership with Bloom Energy, which aims to deploy up to 2.8 gigawatts of fuel cell capacity to meet the surging power demands of AI and cloud data centers. The community is actively debating the stock's long-term technical support levels and the company's aggressive move into on-site energy infrastructure to bypass grid limitations.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as the stock breaks out of a long-term consolidation phase, fueled by high-profile AI infrastructure deals with Meta and Anthropic that have surged daily trading volume. The community is heavily focused on the stock's potential for a massive short squeeze, with active debates centered on whether this rally represents a fundamental shift in AI compute leadership or a speculative bubble driven by heavy institutional options flow.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing significant attention following its strategic partnership with OpenAI, which aims to accelerate drug discovery and optimize supply chain efficiency through AI integration. The community is actively debating the company's long-term competitive moat against Eli Lilly, weighing the potential for AI-driven operational scaling against ongoing market concerns regarding GLP-1 pricing pressures and clinical trial competition.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently drawing intense investor attention as anticipation builds for the upcoming launch of BlueBird 7 on Blue Origin's New Glenn rocket. The community is actively debating the significance of recent operational silence, speculating on potential strategic partnerships with major tech giants, and tracking logistical clues like heavy cargo transport to the company's Midland, Texas facility.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is attracting heavy investor attention as speculation intensifies over a potential leadership shake-up in the Justice Department that could accelerate the long-awaited rescheduling of cannabis to Schedule III. While retail traders are actively debating whether the stock is a prime candidate for a short squeeze or a long-term value play, the community is closely monitoring political developments and the upcoming April 20th timeline as key catalysts for a potential sector-wide reversal.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is surging following reports that Amazon is in advanced talks to acquire the company, fueling intense community speculation about a potential bidding war with SpaceX. Investors are actively debating the true strategic valuation of Globalstar's rare L-band and S-band spectrum assets, with many long-term shareholders pushing back against reported buyout figures as significant undervaluation.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is surging as investors pivot toward its copper-based connectivity solutions after Broadcom's leadership reaffirmed that hyperscalers will prioritize copper over optical modules for AI data center infrastructure. The community is actively debating the strategic trade-off between copper and silicon photonics, with many traders viewing the stock as an undervalued "picks and shovels" play in the AI hardware race.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors capitalize on the high-profile Artemis II moon flyby and significant excitement surrounding the anticipated SpaceX IPO. The community is actively debating the stock's long-term growth potential and institutional accumulation, while monitoring the ongoing tension between optimistic contract-driven momentum and concerns regarding share dilution.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is experiencing a significant surge in investor interest and volatility following the full FDA approval of FILSPARI, its lead therapy for a rare kidney disease. The community is actively debating the potential for a massive short squeeze due to high institutional ownership and short interest, while analysts and retail traders speculate on the stock's future valuation and the likelihood of a near-term buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have received a consensus rating of "Moderate Buy" from the six analysts that are presently covering the firm, Marketbeat Ratings...

Stevanato Group S.p.A. $STVN Stock Position Raised by Cooper Investors PTY Ltd.

Cooper Investors PTY Ltd. boosted its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 17.8% in the fourth quarter, according to the company in its most recent 13F filing with the...

Stevanato Group (NYSE:STVN) Reaches New 1-Year Low  - What's Next?

Stevanato Group (NYSE:STVN) Sets New 1-Year Low - Should You Sell...

Stevanato Group S.p.A. $STVN Shares Bought by Bamco Inc. NY

Bamco Inc. NY grew its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities and...

Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decline in Short Interest

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 1,539,632 shares, a...

ArrowMark Colorado Holdings LLC Grows Position in Stevanato Group S.p.A. $STVN

ArrowMark Colorado Holdings LLC increased its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 6.7% in the 3rd quarter, according to its most recent filing with the SEC. The...

Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six ratings firms that are presently covering the stock, Marketbeat.com...

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...

Morgan Stanley Has Lowered Expectations for Stevanato Group (NYSE:STVN) Stock Price

Morgan Stanley decreased their price objective on Stevanato Group from $24.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday...

Stevanato Group (NYSE:STVN) Given New $26.00 Price Target at Citigroup

Citigroup reduced their price objective on Stevanato Group from $32.00 to $26.00 and set a "buy" rating for the company in a research report on Thursday...

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Stevanato Group Spa

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

Current Price	$13.81
Prev Close	$13.52
Open	$13.52
Dividend Yield	N/A
50-Day Moving Average	$14.98
Beta	0.82
Avg. Volume	586,193.58
PE Ratio	23.69

52-Week High	$28.00
52-Week Low	$12.89
Market Capitalization	$3.69B
EPS (Annual)	$0.5782
Price to Book	2.16
Revenue Per Employee	N/A

STVN
Stevanato Group Spa

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STVN News

STVNStevanato Group Spa